FDA/Duke-Margolis Institute for Health Policy Virtual Public Meeting: Innovation in Quantitative Medicine Summit September 1, 2026

Meeting | Virtual

• Date: September 1, 2026
• Time: 12:00 p.m. - 4:00 p.m. ET

Register

About this Event

The Duke-Margolis Institute for Health Policy and the U.S. Food and Drug Administration's (FDA) Quantitative Medicine Center of Excellence (QM CoE) will co-convene a virtual workshop to inform the establishment of the Quantitative Medicine Innovation Network (QMIN). The QMIN will bring together stakeholders for a cross-sector collaboration of quantitative medicine (QM) to fundamentally transform drug development and clinical care. The sessions will identify priority scientific and regulatory gaps that a coordinated network is uniquely positioned to address, examine lessons learned from established collaborative models in and adjacent to the drug development space, and discuss the governance structures, incentive frameworks, and resource-sharing mechanisms needed to sustain meaningful participation. Participants will consider strategies to build a durable network capable of driving adoption of QM approaches across the drug development lifecycle.

Learn more about the workshop and register here.

For questions regarding this event, please contact CDERQuantMed@fda.hhs.gov.